byssinosis: An occupational lung disorder caused by exposure to cotton dust. It occurs more commonly in workers in the textile industry. Signs and symptoms include chest tightness, cough and wheezing. The symptoms tend to get worse at the beginning of the week and subside by the end of the week.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
92 |
4. Check minimum number of eventsNone |
92 |
5. Include endpointsNone |
92 |
6. Filter based on genotype QC (FinnGen only) |
92 |
Control definitions (FinnGen only)
- Control exclude
- J10_EXTERLUNG
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- J60-J70
- Name in latin
- Morbus viarum respiratoriarum e pulvere organico specifico
Similar endpoints
↥List of similar endpoints to
Airway disease due to specific organic dust
based on the number of shared cases.
Similar with more cases:
- Lung diseases due to external agents
- Diagnoses used for exclusion with ILD
- Other pulmonary diagnosis
- Excluding asthma or asthma-COPD overlap
- COPD differential diagnosis
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 675 | 305 | 364 |
| Only index persons | 584 | 272 | 312 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 45.30 | 44.90 | 45.45 |
| Only index persons | 44.00 | 44.43 | 43.61 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 92 | 49 | 43 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 45.22 | 41.06 | 49.96 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 80
- Matched controls
- 800
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J66.8
ICD-10 Finland
Airway disease due to other specific organic dusts
+∞
78.6
62
*
J45.9
ICD-10 Finland
Asthma, unspecified
5.9
10.5
34
89
J45.0
ICD-10 Finland
Predominantly allergic asthma
8.8
10.4
23
35
J67.0
ICD-10 Finland
Farmer lung
+∞
8.5
8
*
J66.0
ICD-10 Finland
Byssinosis
+∞
7.4
7
*
R03AC02
ATC
salbutamol; inhalant
3.7
7.1
56
310
XG410
NOMESCO Finland
Flow-volume spirometry
14.0
6.3
10
8
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
16.6
6.1
9
6
J30.3
ICD-10 Finland
Other allergic rhinitis
16.6
6.1
9
6
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013115) Eosinophils [#/volume] in Blood
59
378
2.56
4.47
9.4
5.6
e9/l
0.2
0.2
0.40
54
343
(3006315) Basophils [#/volume] in Blood
56
371
2.30
3.66
8.9
5.2
e9/l
0.0
0.0
0.72
51
334
(3001604) Monocytes [#/volume] in Blood
56
371
2.30
3.66
8.6
5.2
e9/l
0.6
0.5
1.42
51
330
(3019198) Lymphocytes [#/volume] in Blood
56
378
2.23
3.41
9.0
5.3
e9/l
2.1
2.0
0.48
51
342
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
17
5.04
2.99
2.4
1.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
17
79
2.41
2.43
2.1
1.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
6
14
4.50
2.19
1.0
1.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
35
231
1.83
1.98
8.9
5.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
31
198
1.85
1.94
4.5
4.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
45
325
1.75
1.87
7.6
6.2
mmol/l
1.2
1.2
0.67
39
279
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
6
19
3.30
1.69
3.2
2.1
mg/l
10.4
8.9
—
6
19
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
21
124
1.90
1.65
1.5
1.4
u/ml
7.1
19.5
0.84
12
56
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
15
3.46
1.54
1.0
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
21
129
1.81
1.46
1.5
1.3
iu/ml
13.0
26.4
—
9
55
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
22
2.84
1.46
2.5
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
6
22
2.84
1.46
3.2
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
5
16
3.24
1.45
1.0
1.8
—
2.6
—
0
5
(3022313) Gas panel - Capillary blood
6
25
2.49
1.26
13.8
2.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
8
37
2.27
1.25
10.8
2.2
mmol/l
1.3
1.1
—
8
28
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
38
2.21
1.22
1.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
24
335
0.62
1.20
2.8
2.7
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
8
39
2.15
1.18
10.7
2.2
kpa
5.9
5.0
—
8
33
(3011288) Drugs identified in Urine by Screen method
5
20
2.58
1.16
1.4
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
15
89
1.82
1.16
1.2
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
16
97
1.79
1.16
1.6
2.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
17
106
1.74
1.12
2.6
1.8
—
—
—
0
0
(4010399)
10
52
2.04
1.11
1.3
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
9
47
2.01
1.06
3.3
4.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
58
490
1.50
1.04
6.4
3.6
—
—
—
0
0
(3000492) Spirometry study
12
69
1.85
1.02
2.2
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
13
78
1.78
0.97
2.6
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
20
137
1.59
0.94
3.9
4.1
ng/l
159.8
173.9
0.03
13
99
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
8
42
1.99
0.91
2.1
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
22
156
1.54
0.90
1.4
1.2
u/ml
0.5
1.4
—
6
43
(3013139) Helicobacter pylori Ag [Presence] in Stool
8
46
1.81
0.85
1.4
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
76
813
0.63
0.83
18.8
12.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
15
216
0.63
0.82
1.5
1.4
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
0
24
0.00
0.80
0.0
1.0
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
83
867
0.56
0.78
27.9
18.5
e9/l
6.9
6.7
0.56
83
844
(3024731) MCV [Entitic volume]
83
866
0.58
0.77
27.6
18.3
fl
91.3
90.8
0.37
83
854
(3000963) Hemoglobin [Mass/volume] in Blood
83
866
0.58
0.77
27.9
18.5
g/l
136.9
137.5
0.14
83
855
(3026361) Erythrocytes [#/volume] in Blood
83
866
0.58
0.77
27.7
18.3
e12/l
4.5
4.6
0.06
83
842
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
5
23
2.24
0.77
1.2
1.2
g/l
0.2
0.3
—
5
23
(3035941) MCH [Entitic mass]
83
865
0.59
0.76
27.6
18.3
pg
30.3
30.4
0.10
83
853
(3007461) Platelets [#/volume] in Blood
83
865
0.59
0.76
28.0
18.4
e9/l
254.6
250.5
0.28
83
843
(3018418) pH of Serum or Plasma
26
199
1.43
0.73
2.9
3.8
ph
7.4
7.4
—
7
40
(3044640) Blood type and Crossmatch panel - Blood
27
209
1.41
0.72
2.4
2.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
7
41
1.76
0.72
1.1
1.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
7
41
1.76
0.72
2.7
2.5
mmol/l
26.1
24.6
—
7
41
(3023368) Bacteria identified in Blood by Culture
24
182
1.43
0.71
3.6
3.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
7
44
1.64
0.67
1.4
2.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
35
288
1.35
0.64
3.4
2.3
nmol/l
76.6
77.3
0.05
35
267
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
20
0.00
0.61
0.0
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
33
271
1.34
0.61
2.2
1.8
pmol/l
96.4
99.0
0.15
21
126
(3032080) INR in Blood by Coagulation assay
34
282
1.33
0.58
16.6
7.6
inr
1.2
1.1
0.29
11
96
(40758558) Short blood count panel - Blood
23
181
1.36
0.55
9.6
7.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
19
146
1.38
0.52
1.8
1.3
g/l
1.9
2.6
0.88
14
87
(3001019) Free T4 and TSH panel - Serum or Plasma
7
45
1.60
0.50
1.7
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
75
789
0.73
0.46
4.4
5.0
mmol/l
2.7
2.8
0.24
70
739
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
6
91
0.64
0.45
1.3
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
6
93
0.62
0.45
4.0
7.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
5
31
1.65
0.44
2.4
1.3
—
—
—
0
0
(4035726)
8
57
1.44
0.43
1.1
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
18
142
1.33
0.42
2.4
3.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
34
1.50
0.41
2.8
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.7
—
113.0
—
0
6
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
8
111
0.69
0.40
1.7
1.5
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
13
99
1.36
0.38
2.5
2.3
umol/l
12.1
14.3
0.54
13
93
(3002385) Erythrocyte distribution width [Ratio]
61
652
0.81
0.37
19.8
15.2
%
13.9
13.6
0.70
61
645
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
54
496
1.21
0.35
3.0
3.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
6
86
0.68
0.35
8.0
4.5
ug/l
2.9
91.8
—
6
68
(40768797) Stomach Pathology biopsy report
13
101
1.33
0.34
1.1
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
7
52
1.37
0.32
5.7
2.8
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
39
350
1.20
0.32
3.8
3.2
estimate
0.0
0.0
—
9
82
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
29
253
1.21
0.31
2.9
3.2
u/l
25.9
32.2
1.09
29
240
(3021589) Normoblasts [#/volume] in Blood
38
342
1.19
0.30
9.8
9.6
e9/l
0.0
0.0
0.32
30
286
(3023103) Potassium [Moles/volume] in Serum or Plasma
76
788
0.80
0.28
18.5
13.8
mmol/l
4.0
4.0
0.10
76
768
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
60
564
1.18
0.27
4.6
3.9
pmol/l
15.0
14.8
0.23
53
522
(40768804) Tissue Pathology biopsy report
32
286
1.18
0.27
2.0
1.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
39
356
1.17
0.25
5.6
4.3
estimate
0.0
0.0
—
9
78
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
17
198
0.83
0.23
4.2
4.0
%
16.7
21.6
—
10
82
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
32
289
1.16
0.23
3.8
3.1
ng/l
92.7
27.2
0.53
23
194
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
69
718
0.84
0.23
14.6
11.5
ml/min/173m2
83.6
83.6
0.01
62
585
(3012516) Albumin [Mass/volume] in Urine
22
193
1.18
0.22
3.6
3.4
mg/l
70.2
52.0
0.12
12
129
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
67
697
0.86
0.21
5.5
4.6
mu/l
1.7
1.9
0.74
61
645
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
0
13
0.00
0.21
0.0
2.2
—
129.0
—
0
7
(3015736) pH of Urine
30
272
1.15
0.20
3.0
2.9
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
76
783
0.83
0.20
18.6
13.8
mmol/l
140.1
139.7
1.24
76
764
(3009261) Glucose [Presence] in Urine by Test strip
39
361
1.14
0.20
3.8
3.2
estimate
0.0
0.0
—
9
75
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
25
224
1.16
0.20
2.3
2.1
u/l
97.0
271.9
1.39
25
212
(3036481) Cortisol [Moles/volume] in Serum or Plasma
10
81
1.26
0.19
1.7
1.7
nmol/l
329.0
347.7
—
10
76
(3013512) EKG study
20
225
0.86
0.19
4.6
3.2
—
—
—
0
0
(3019225) pH of Specimen
7
59
1.20
0.18
10.4
4.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
68
704
0.87
0.18
17.0
12.9
%
39.2
40.6
0.43
49
529
(3002256) Pathology report gross observation
10
82
1.25
0.18
1.3
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
17
192
0.86
0.16
3.4
2.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
9
78
1.17
0.16
2.7
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
9
80
1.14
0.16
2.7
1.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
31
331
0.90
0.13
4.5
4.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
16
143
1.14
0.12
2.8
2.2
e6/l
3.4
3.5
0.04
16
126
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
69
708
0.90
0.11
6.1
5.4
mmol/mol
41.7
39.6
0.71
63
667
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
17
155
1.12
0.10
3.1
2.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
6
57
1.06
0.09
1.5
1.2
—
32.9
—
0
5
(3019832) Treponema pallidum Ab [Presence] in Serum
7
64
1.10
0.08
1.9
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
14
153
0.90
0.08
1.1
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9
85
1.07
0.07
2.2
2.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
8
93
0.85
0.07
1.3
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
8
93
0.85
0.07
1.6
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
52
534
0.94
0.06
4.4
3.8
—
—
—
0
0
(3026782) Osmolality of Urine
12
130
0.91
0.05
1.9
2.3
mosm/kgh2o
536.0
563.2
0.15
12
110
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
79
780
1.09
0.05
18.8
11.9
mg/l
21.5
22.0
0.06
71
612
(3041096) Erythrocytes [Presence] in Urine by Automated
23
221
1.05
0.03
4.6
2.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
10
108
0.92
0.03
1.1
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
17
178
0.94
0.02
1.6
1.5
mg/l
1.1
1.0
0.08
12
150
(3018095) Leukocytes [#/volume] in Urine
23
237
0.96
0.01
4.1
3.3
e6/l
33.4
77.9
0.47
18
173
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
26
254
1.03
0.00
4.8
4.4
ug/l
4.8
2.0
0.41
26
232
(3020564) Creatinine [Moles/volume] in Serum or Plasma
81
812
0.98
0.00
19.9
14.5
umol/l
84.2
75.5
0.80
81
812
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
24
243
0.98
0.00
4.4
2.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
29
285
1.03
0.00
4.5
3.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
18
185
0.97
0.00
3.0
2.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
19
194
0.97
0.00
4.1
3.4
estimate
0.0
0.0
—
7
80
(3020682) Albumin/Creatinine [Ratio] in Urine
21
206
1.03
0.00
5.7
4.1
mg/mmol
8.6
8.0
0.03
12
131
(3009508) Creatinine [Moles/volume] in Urine
21
211
0.99
0.00
3.9
3.1
mmol/l
7.7
8.1
0.19
16
178
(46235355) HIV 1 and 2 tests - Meaningful Use set
13
131
0.99
0.00
1.8
1.9
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3017704) Immunofixation for Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
0
9
0.00
0.00
0.0
1.4
—
66.7
—
0
9
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
11.8
—
0
6
(3011648) Oxygen content in Venous blood
0
5
0.00
0.00
0.0
1.0
—
11.8
—
0
5
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
5
0.00
0.00
0.0
8.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
79
1.01
0.00
1.8
2.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
245.9
—
0
7
(3004616) Nuclear Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
9.7
—
0
6
(40761536) Microorganisms panel - Urine sediment
6
68
0.87
0.00
3.7
3.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
9
0.00
0.00
0.0
2.0
—
32.3
—
0
9
(4211845)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.2
—
99.5
—
0
6
(3019230) Fractional oxyhemoglobin in Venous blood
0
9
0.00
0.00
0.0
1.0
—
66.0
—
0
9
(3051611) Lipemic interference index of Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
49.3
—
0
6
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
5
49
1.02
0.00
3.0
2.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
3.9
—
0
9
(1617658) Protocol used for examination of sentinel lymph nodes
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
5
51
0.98
0.00
1.4
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
8
0.00
-0.00
0.0
1.4
—
1.0
—
0
8
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
8
0.00
-0.00
0.0
4.9
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
8
0.00
-0.00
0.0
5.8
—
142.1
—
0
8
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint J10_AIRWDISDUST and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have J10_AIRWDISDUST.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: J10_AIRWDISDUST – Airway disease due to specific organic dust
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data